| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.50▼ | 1.50▼ | 1.51▼ | 1.53▼ | 1.50▼ |
| MA10 | 1.51▼ | 1.54▼ | 1.55▼ | 1.49▼ | 1.30▲ |
| MA20 | 1.56▼ | 1.56▼ | 1.56▼ | 1.48▼ | 2.41▼ |
| MA50 | 1.62▼ | 1.51▼ | 1.48▼ | 1.29▲ | 10.27▼ |
| MA100 | 1.56▼ | 1.50▼ | 1.50▼ | 2.66▼ | 93.58▼ |
| MA200 | 1.51▼ | 1.40▲ | 1.30▲ | 8.55▼ | 475.91▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.008▼ | -0.018▼ | -0.016▼ | 0.015▲ | 1.024▲ |
| RSI | 36.099▼ | 43.390▼ | 45.744▼ | 50.190▲ | 26.119▼ |
| STOCH | 11.346▼ | 12.857▼ | 9.048▼ | 28.475 | 35.338 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -76.119▼ | -80.573▼ |
| CCI | -102.034▼ | -105.954▼ | -106.081▼ | -31.764 | -17.476 |
|
Friday, January 24, 2020 09:15 AM
Tonix Pharmaceuticals (NASDAQ:TNXP) has completed fed-fasting and dose proportionality tests of TNX-102 SL in healthy volunteers, data that, it says, should satisfy the pharmacokinetic requirements ...
|
|
Friday, January 24, 2020 07:08 AM
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) revealed Friday that it had successfully completed the required fed-fasting and dose proportionality tests of its lead product candidate, Tonmya, or ...
|
|
Friday, January 24, 2020 05:32 AM
Tonmya, or TNX-102 SL, is a low-dose cyclobenzaprine sublingual tablet, in Phase 3 development as a treatment for PTSD and fibromyalgia Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) revealed Friday ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 29/01/20 | 1.48 | 1.48 | 1.47 | 1.47 | 282,561 |
| 28/01/20 | 1.67 | 1.67 | 1.49 | 1.52 | 900,600 |
| 27/01/20 | 1.49 | 1.67 | 1.44 | 1.64 | 1,115,100 |
| 24/01/20 | 1.82 | 1.98 | 1.52 | 1.63 | 15,354,600 |
| 23/01/20 | 1.40 | 1.43 | 1.35 | 1.39 | 406,400 |
| 22/01/20 | 1.39 | 1.41 | 1.31 | 1.31 | 647,900 |
| 21/01/20 | 1.35 | 1.44 | 1.33 | 1.43 | 825,000 |
| 17/01/20 | 1.50 | 1.59 | 1.47 | 1.55 | 517,500 |
| 16/01/20 | 1.39 | 1.59 | 1.39 | 1.58 | 613,600 |
| 15/01/20 | 1.45 | 1.48 | 1.34 | 1.39 | 763,100 |
|
|
||||
|
|
||||
|
|